NCT03872700View on ClinicalTrials.gov

Intranasal Fentanyl as an Adjunct to Lidocaine Infiltration in Adults Undergoing Abscess Incision and Drainage

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions

Abscess

Interventions

DRUG

Intranasal fentanyl

Fentanyl Citrate

DRUG

Placebo

Sterile Water Up to 5Cc

Trial Locations (1)

10467

Montefiore Medical Center, The Bronx

All Listed Sponsors

lead

Montefiore Medical Center

OTHER

NCT03872700 - Intranasal Fentanyl as an Adjunct to Lidocaine Infiltration in Adults Undergoing Abscess Incision and Drainage | Biotech Hunter | Biotech Hunter